Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DTE Energy's Q4 Earnings Beat Estimates, Increase Year Over Year
DTE Energy's Q4 Earnings Beat Estimates, Increase Year Over Year

DTE Energy Company DTE reported fourth-quarter 2025 operating earnings per share (EPS) of $1.65, which beat the Zacks Consensus Estimate of $1.52 by 8.6%. The bottom line increased 9.3% from the

MongoDB Benefits From a Strong Partner Network: Can it Drive Growth?
MongoDB Benefits From a Strong Partner Network: Can it Drive Growth?

MongoDB's MDB expanding partner network is emerging as a structural growth lever, embedding the platform deeper into the modern enterprise software stack. Integrations with LangChain for AI

Can Rising Defense Demand Boost Celestica's Future Growth Prospects?
Can Rising Defense Demand Boost Celestica's Future Growth Prospects?

Celestica Inc. CLS plays a key role in the global defense industry by designing, engineering and manufacturing high-reliability electronic systems for mission-critical military applications. It acts

Will the Iron Drone Raider Win Ignite Ondas' Long-Term Growth Engine?
Will the Iron Drone Raider Win Ignite Ondas' Long-Term Growth Engine?

Ondas Inc. ONDS has taken a major initiative to commercialize its autonomous defense technologies. Through its subsidiary Airobotics, the company has secured a new multi-million-dollar order from a

Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer

Novocure NVCR recently announced the FDA approval for its portable therapeutic device, Optune Pax, for treating adult patients with locally advanced pancreatic cancer concomitant with gemcitabine

Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth
Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth

The market expects Jazz Pharmaceuticals (JAZZ) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known

Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?
Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Kiniksa Pharmaceuticals International, plc (KNSA) reports results for the quarter ended December 2025. While this

MGE (MGEE) Earnings Expected to Grow: Should You Buy?
MGE (MGEE) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when MGE (MGEE) reports results for the quarter ended December 2025. While this widely-known consensus outlook is

Analysts Estimate Matador Resources (MTDR) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Matador Resources (MTDR) to Report a Decline in Earnings: What to Look Out for

The market expects Matador Resources (MTDR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Par Petroleum (PARR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Par Petroleum (PARR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Wall Street expects a year-over-year increase in earnings on lower revenues when Par Petroleum (PARR) reports results for the quarter ended December 2025. While this widely-known consensus outlook

Interparfums (IPAR) Expected to Beat Earnings Estimates: Should You Buy?
Interparfums (IPAR) Expected to Beat Earnings Estimates: Should You Buy?

Interparfums (IPAR) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

Earnings Preview: VERRA MOBILITY CORP (VRRM) Q4 Earnings Expected to Decline
Earnings Preview: VERRA MOBILITY CORP (VRRM) Q4 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on higher revenues when VERRA MOBILITY CORP (VRRM) reports results for the quarter ended December 2025. While this widely-known consensus

Workday (WDAY) Earnings Expected to Grow: Should You Buy?
Workday (WDAY) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Workday (WDAY) reports results for the quarter ended January 2026. While this widely-known consensus outlook is

Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Wall Street expects a year-over-year increase in earnings on higher revenues when Inogen (INGN) reports results for the quarter ended December 2025. While this widely-known consensus outlook is

Analysts Estimate Portillo's Inc. (PTLO) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Portillo's Inc. (PTLO) to Report a Decline in Earnings: What to Look Out for

Portillo's Inc. (PTLO) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline
Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on higher revenues when Supernus Pharmaceuticals (SUPN) reports results for the quarter ended December 2025. While this widely-known

Talos Energy (TALO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Talos Energy (TALO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Wall Street expects a year-over-year decline in earnings on lower revenues when Talos Energy (TALO) reports results for the quarter ended December 2025. While this widely-known consensus outlook is

Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Tarsus Pharmaceuticals, Inc. (TARS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known

Planet Fitness (PLNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Planet Fitness (PLNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Planet Fitness (PLNT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

Henry Schein (HSIC) Earnings Expected to Grow: Should You Buy?
Henry Schein (HSIC) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Henry Schein (HSIC) reports results for the quarter ended December 2025. While this widely-known consensus outlook

Home Depot (HD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Home Depot (HD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Wall Street expects a year-over-year decline in earnings on lower revenues when Home Depot (HD) reports results for the quarter ended January 2026. While this widely-known consensus outlook is

Earnings Preview: Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Expected to Decline
Earnings Preview: Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Expected to Decline

The market expects Harmony Biosciences Holdings, Inc. (HRMY) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This

Earnings Preview: International General Insurance Holdings Ltd. (IGIC) Q4 Earnings Expected to Decline
Earnings Preview: International General Insurance Holdings Ltd. (IGIC) Q4 Earnings Expected to Decline

International General Insurance Holdings Ltd. (IGIC) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This

First Watch Restaurant Group, Inc. (FWRG) Earnings Expected to Grow: Should You Buy?
First Watch Restaurant Group, Inc. (FWRG) Earnings Expected to Grow: Should You Buy?

The market expects First Watch Restaurant Group, Inc. (FWRG) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This

First Solar (FSLR) Reports Next Week: Wall Street Expects Earnings Growth
First Solar (FSLR) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when First Solar (FSLR) reports results for the quarter ended December 2025. While this widely-known consensus outlook